Revance Therapeutics Inc (RVNC)

[Bickema]

Pfizer is an obvious candidate but there are many others too considering the pros of the aesthetics space.

Whats fun to look back on is that Pfizer was trying to buy Allergan back in Nov of 2015 when Allergan was trading at around $300 a share(!)

Now allergan trades at almost half that price! Ofcourse dodging that bullet doesn't mean Pfizer should buy RVNC, Pfizer Allergan deal was incentivized by a lower tax rate.

Mylan and Johnson and Johnson are both candidates as well. but again there should be a long list of potential suitors.

As far as price goes, there is still a lot of funding needed to finish trials, manufacture, and market rt002 so with that in mind a price tag of 2 billion seems reasonable. thoughts?